Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 6, 2004, Pages 386-388

  Quinn, Charles T ^a,d   Griener, James C ^b   Bottiglieri, Teodoro ^c   Arning, Erland ^c   Winick, Naomi J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adenosine; Central nervous system; Cerebrospinal fluid; Folate; Homocysteine; Methotrexate

Indexed keywords

ADENOSINE; EXCITATORY AMINO ACID; FOLIC ACID; HOMOCYSTEINE; METHOTREXATE; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; ARTICLE; BRAIN LYMPHOMA; BRAIN METABOLISM; BURKITT LYMPHOMA; CASE REPORT; CEREBROSPINAL FLUID; CHILD; DRUG EFFECT; DRUG MECHANISM; FOLATE METABOLISM; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL;

AMINO ACIDS; ANTIMETABOLITES, ANTINEOPLASTIC; BURKITT LYMPHOMA; CHILD, PRESCHOOL; EPINEPHRINE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; METHOTREXATE; NEOPLASM STAGING;

EID: 2942616544     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200406000-00011     Document Type: Article

References (13)

1. Quinn CT, Kamen BA. A biochemical perspective of methotrexate neunrotoxicity with insight on nonfolate rescue modalities. J Investig Med. 1996;44:522-530.
2. Vezmar S, Becker A, Bode U, et al. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy. 2003;49:92-104.
3. 2 intravenous methotrexate. Pediatr Res. 1995;37:151-154.
4. Silverstein FS, Hutchinson RJ, Johnston MV. Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia. Pediatr Res. 1986;20:285-291.
5. Surtees R, Clelland J, Hann I. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. J Clin Oncol. 1998;16:1505-1511.
6. Bernini JC, Fort DW, Griener JC, et al. Aminophylline for methotrexate-induced neurotoxicity. Lancet. 1995;345:544-547.
7. Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol. 1997;15:2800-2806.
8. Quinn CT, Griener JC, Bottiglieri T, et al. Methotrexate, homocysteine, and seizures. J Clin Oncol. 1998;16:393-394.
9. Millot F, Chastagner P, Dhondt J, et al. Substitutive therapy in a case of methotrexate neurotoxicity. Eur J Cancer. 1992;28A:1935.
10. Johnston MV, Silverstein FS, Greenberg H, et al. Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolites in rhesus monkeys. Cancer Treat Rep. 1986;70:1205-1209.
11. Barth A, Newell DW, Nguyen LB, et al. Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide. Brain Res. 1997;762:79-88.
12. Ho PI, Ortiz D, Rogers E, et al. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002;70:694-702.
13. Chang WJ, Rothberg KG, Kamen BA, et al. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J Cell Biol. 1992;118:63-69.